Safety and Pharmacokinetics of Oral F901318 (Fluconazole and Posaconazole) IN Aml Leukaemia

NCT03036046 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study no longer required

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: F901318 with fluconazole low dose
DRUG: F901318 with fluconazole high dose
DRUG: F901318 with posaconazole

Sponsor

F2G Ltd

Collaborators

[object Object]
[object Object]
[object Object]